Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arthur M Friedlander

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
The Journal of Biological Chemistry|July 10, 2010
Human transferrin confers serum resistance against Bacillus anthracisSuzan H M Rooijakkers, Suzanne L Rasmussen, Shauna M McGillivray, et al.
Plos Pathogens|September 29, 2022
The capsule of Bacillus anthracis protects it from the bactericidal activity of human defensins and other cationic antimicrobial peptidesDavid K O'Brien, Wilson J Ribot, Donald J Chabot, et al.
Microbiology (Reading, England)|March 1, 1996
Characterization of lethal factor binding and cell receptor binding domains of protective antigen of Bacillus anthracis using monoclonal antibodiesStephen F Little, Jeanne M Novak, John R Lowe, et al.
Infection and Immunity|June 4, 2014
Exposure to Bacillus anthracis capsule results in suppression of human monocyte-derived dendritic cellsTanya M Jelacic, Donald J Chabot, Joel A Bozue, et al.
Infection and Immunity|August 24, 2006
Anthrax lethal toxin impairs innate immune functions of alveolar macrophages and facilitates Bacillus anthracis survivalWilson J Ribot, Rekha G Panchal, Katherine C Brittingham, et al.
MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports|December 14, 2019
Use of Anthrax Vaccine in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2019William A Bower, Jarad Schiffer, Robert L Atmar, et al.
Vaccine|January 31, 2002
Anthrax vaccine: immunogenicity and safety of a dose-reduction, route-change comparison study in humansPhillip R Pittman, Gina Kim-Ahn, Dominique Y Pifat, et al.
ACS Infectious Diseases|September 14, 2022
Engineering an Fc-Fusion of a Capsule Degrading Enzyme for the Treatment of AnthraxKhushie Matharoo, Jennifer Chua, Junyoung R Park, et al.
Vaccine|December 17, 2011
Efficacy of a capsule conjugate vaccine against inhalational anthrax in rabbits and monkeysDonald J Chabot, Joseph Joyce, Michael Caulfield, et al.
Science Translational Medicine|December 8, 2021
Treatment of experimental anthrax with pegylated circularly permuted capsule depolymerasePatricia M Legler, Stephen F Little, Jeffrey Senft, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
The Journal of Biological Chemistry|July 10, 2010
Human transferrin confers serum resistance against Bacillus anthracisSuzan H M Rooijakkers, Suzanne L Rasmussen, Shauna M McGillivray, et al.
Plos Pathogens|September 29, 2022
The capsule of Bacillus anthracis protects it from the bactericidal activity of human defensins and other cationic antimicrobial peptidesDavid K O'Brien, Wilson J Ribot, Donald J Chabot, et al.
Microbiology (Reading, England)|March 1, 1996
Characterization of lethal factor binding and cell receptor binding domains of protective antigen of Bacillus anthracis using monoclonal antibodiesStephen F Little, Jeanne M Novak, John R Lowe, et al.
Infection and Immunity|June 4, 2014
Exposure to Bacillus anthracis capsule results in suppression of human monocyte-derived dendritic cellsTanya M Jelacic, Donald J Chabot, Joel A Bozue, et al.
Infection and Immunity|August 24, 2006
Anthrax lethal toxin impairs innate immune functions of alveolar macrophages and facilitates Bacillus anthracis survivalWilson J Ribot, Rekha G Panchal, Katherine C Brittingham, et al.
MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports|December 14, 2019
Use of Anthrax Vaccine in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2019William A Bower, Jarad Schiffer, Robert L Atmar, et al.
Vaccine|January 31, 2002
Anthrax vaccine: immunogenicity and safety of a dose-reduction, route-change comparison study in humansPhillip R Pittman, Gina Kim-Ahn, Dominique Y Pifat, et al.
ACS Infectious Diseases|September 14, 2022
Engineering an Fc-Fusion of a Capsule Degrading Enzyme for the Treatment of AnthraxKhushie Matharoo, Jennifer Chua, Junyoung R Park, et al.
Vaccine|December 17, 2011
Efficacy of a capsule conjugate vaccine against inhalational anthrax in rabbits and monkeysDonald J Chabot, Joseph Joyce, Michael Caulfield, et al.
Science Translational Medicine|December 8, 2021
Treatment of experimental anthrax with pegylated circularly permuted capsule depolymerasePatricia M Legler, Stephen F Little, Jeffrey Senft, et al.
Pageof 6